Category

Therapeutic Areas

Home > Therapeutic Areas (Page 55)

García Dorado M, Quintero J, Gonzalez Martin del Moro B, Cuervo-Arango I, Oyagüez I

 

Cost minimization analysis comparing paliperidone palmitate long-acting inyectable with risperidone long-acting inyectable in Spain
XVIII Congreso Sociedad Española de Psiquiatría (SEP). Santiago de Compostela, España. 24-26 sep 2015

Berlana D, Almendral MA, Abad MR, Fernández A, Torralba A, Cervera M, Piñeiro G, Romero-Jiménez R, Vázquez A, Ramírez E, Marced-Barrachina E, Muñoz A, Torres C

 

Economic assessment in the preparation of parenteral nutrition: Manual compounded bags versus three-chamber bags. Nutripar study
37th European Society For Clinical Nutrition And Metabolism Congress (ESPEN). Lisboa, Portugal. 5-8 sep 2015

Jiménez-Ruiz CA, Solano-Reina S, Signes-Costa J, de Higes-Martinez E, Granda-Orive JI, Lorza-Blasco JJ, Riesco-Miranda JA, Altet-Gomez N, Barrueco-Ferrero M, Oyagüez I, Rejas J

 

Budgetary Impact Analysis on Funding Smoking-cessation Drugs in Patients with Chronic Obstructive Pulmonary Disease in Spain
Int J Chron Obstruct Pulmon Dis. 2015;10:2027-36

Gros B, Galan A, Gonzalez-Parra E, Herrero JA, Echave M, Vegter S, Tolley K, Oyagüez I

 

 

Cost effectiveness of Lanthanum Carbonate in chronic kidney disease patients in Spain before and during dialysis
Health Econ Rev. 2015;5:14 doi:10.1186/s13561-015-0049-3

Romero-Gómez M, Turnes J, Ampuero J, Oyagüez I, Cuenca B, González-García J, Muñoz-Molina B, Aguilar R, Leal S, Planas R, García-Samaniego J, Diago M, Crespo J, Calleja JL, Casado MA, Solà R

 

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: The Optim Study
PLoS One.2015;10(3):e0122613.doi:10.1371/journal.pone.0122613

Gros B, Soto J, Casado MA

 

 

 

Incorporation of future costs in health economic analysis publications: Current situation and recommendations for the future
Expert Rev Pharmacoecon Outcomes Res. 2015;15(3):465-9